Consensus paper-ICIS expert meeting Basel 2009 treatment milestones in immune thrombocytopenia

Annals of Hematology

Volumn 89, Issue SUPPL. 1, 2010, Pages

  Tamary, Hannah ^a   Roganovic, Jelena ^b   Chitlur, Meera ^c   Nugent, Diane J ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b KBC RIJEKA   (Croatia)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Immune; Outcomes; Thrombocytopenia; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; ELTROMBOPAG; HEMOSTATIC AGENT; MERCAPTOPURINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; ROMIPLOSTIM; THROMBOPOIETIN RECEPTOR AGONIST; UNCLASSIFIED DRUG; VINCRISTINE; BENZOIC ACID DERIVATIVE; FC RECEPTOR; HYBRID PROTEIN; HYDRAZINE DERIVATIVE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; PYRAZOLE DERIVATIVE; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL OBSERVATION; CONFERENCE PAPER; CONSERVATIVE TREATMENT; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEDICAL DECISION MAKING; MEDICAL EXPERT; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; SCORING SYSTEM; SPLENECTOMY; THROMBOCYTE COUNT; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY; ADULT; AGONISTS; CHILD; CONSENSUS DEVELOPMENT; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PSYCHOLOGY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEVERITY OF ILLNESS INDEX; SWITZERLAND; THROMBOCYTOPENIA;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BENZOATES; CHILD; HEMORRHAGE; HUMANS; HYDRAZINES; IMMUNOLOGIC FACTORS; PRECISION MEDICINE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; PYRAZOLES; QUALITY OF LIFE; RECEPTORS, FC; RECEPTORS, THROMBOPOIETIN; RECOMBINANT FUSION PROTEINS; RITUXIMAB; SEVERITY OF ILLNESS INDEX; SPLENECTOMY; SWITZERLAND; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 77955657061     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0941-1     Document Type: Conference Paper

References (31)

1. PH Bolton-Maggs I Moon 1997 Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines Lancet 350 9078 620 623 10.1016/S0140-6736(97)04143-3 1:STN:280: DyaK2svjsVWmug%3D%3D 9288044
2. JN George SH Woolf GE Raskob JS Wasser LM Aledort PJ Ballem, et al. 1996 Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 88 1 3 40 1:CAS:528:DyaK28XjvFSnsLo%3D 8704187
3. T Kuhne GR Buchanan S Zimmerman LA Michaels R Kohan W Berchtold, et al. 2003 A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group J Pediatr 143 5 605 608 10.1067/S0022-3476(03)00535-3 14615730
4. JS Lilleyman 1994 Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology Arch Dis Child 71 3 251 253 10.1136/adc.71.3.251 1:STN:280: DyaK2M%2FntVaksw%3D%3D 7979501
5. CE Neunert GR Buchanan P Imbach PH Bolton-Maggs CM Bennett EJ Neufeld, et al. 2008 Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura Blood 112 10 4003 4008 10.1182/blood-2008-03-138487 1:CAS:528:DC%2BD1cXhsVSmsr3N 18698007
6. GR Buchanan L Adix 2002 Grading of hemorrhage in children with idiopathic thrombocytopenic purpura J Pediatr 141 5 683 688 10.1067/mpd.2002.128547 12410198
7. LK Page B Psaila D Provan J Michael Hamilton JM Jenkins AS Elish, et al. 2007 The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP Br J Haematol 138 2 245 248 10.1111/j.1365-2141. 2007.06635.x 17542983
8. S Jayabose O Levendoglu-Tugal MF Ozkaynkak P Visintainer C Sandoval 2004 Long-term outcome of chronic idiopathic thrombocytopenic purpura in children J Pediatr Hematol Oncol 26 11 724 726 10.1097/00043426-200411000-00007 15543006
9. MD Tarantino 2000 Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children Semin Hematol 37 1 Suppl 1 35 41 10.1016/S0037-1963(00)90117-3 1:STN:280:DC%2BD3c7ktVSqsQ%3D%3D 10676923
10. CE Neunert BC Bright GR Buchanan 2008 Severe chronic refractory immune thrombocytopenic purpura during childhood: a survey of physician management Pediatr Blood Cancer 51 4 513 516 10.1002/pbc.21621 18506754
11. G Emilia M Luppi M Morselli F Forghieri L Potenza G Torelli 2008 A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura Haematologica 93 7 1113 1115 10.3324/haematol.12741 1:CAS:528: DC%2BD1cXhsVWis7nI 18508788
12. M Hou J Peng Y Shi C Zhang P Qin C Zhao, et al. 2003 Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura Eur J Haematol 70 6 353 357 10.1034/j.1600-0609.2003.00076.x 1:CAS:528:DC%2BD3sXltlGqt70%3D 12756016
13. A Sobota EJ Neufeld S Lapsia CM Bennett 2009 Response to mercaptopurine for refractory autoimmune cytopenias in children Pediatr Blood Cancer 52 1 80 84 10.1002/pbc.21729 18726904
14. SK Vesely JJ Perdue MA Rizvi DR Terrell JN George 2004 Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review Ann Intern Med 140 2 112 120 14734334
15. SE Crary GR Buchanan 2009 Vascular complications after splenectomy for hematologic disorders Blood 114 14 2861 2868 10.1182/blood-2009-04-210112 1:CAS:528:DC%2BD1MXht12qur7L 19636061
16. DM Arnold F Dentali MA Crowther RM Meyer RJ Cook C Sigouin, et al. 2007 Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura Ann Intern Med 146 1 25 33 17200219
17. A Hasan M Michel V Patel R Stasi S Cunningham-Rundles JP Leonard, et al. 2009 Repeated courses of rituximab in chronic ITP: three different regimens Am J Hematol 84 10 661 665 10.1002/ajh.21512 1:CAS:528:DC%2BD1MXhtlyqsLnL 19731307
18. E Parodi E Rivetti G Amendola G Bisogno R Calabrese P Farruggia, et al. 2009 Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response Br J Haematol 144 4 552 558 10.1111/j.1365-2141.2008.07487.x 1:CAS:528:DC%2BD1MXjtlehtrk%3D 19036077
19. BU Mueller CM Bennett HA Feldman JB Bussel TC Abshire TB Moore, et al. 2009 One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab Pediatr Blood Cancer 52 2 259 262 10.1002/pbc.21757 18937333
20. F Zaja ML Battista MT Pirrotta S Palmieri M Montagna N Vianelli, et al. 2008 Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura Haematologica 93 6 930 933 10.3324/haematol.12206 1:CAS:528:DC%2BD1cXhsVWlur7O 18403395
21. B Godeau R Porcher O Fain F Lefrere P Fenaux S Cheze, et al. 2008 Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study Blood 112 4 999 1004 10.1182/blood-2008-01-131029 1:CAS:528: DC%2BD1cXpvVOksLw%3D 18463354
22. S Aksoy H Harputluoglu S Kilickap DS Dede O Dizdar K Altundag, et al. 2007 Rituximab-related viral infections in lymphoma patients Leuk Lymphoma 48 7 1307 1312 10.1080/10428190701411441 1:CAS:528:DC%2BD2sXnsVyqs74%3D 17613758
23. KR Carson AM Evens EA Richey TM Habermann D Focosi JF Seymour, et al. 2009 Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project Blood 113 20 4834 4840 10.1182/blood-2008-10-186999 1:CAS:528:DC%2BD1MXmslalsbw%3D 19264918
24. I Di Carlo S Primo E Pulvirenti A Toro 2008 Should all splenectomised patients be vaccinated to avoid OPSI? Revisiting an old concept: an Italian retrospective monocentric study Hepatogastroenterology 55 82-83 308 310 18613354
25. T Okabayashi K Hanazaki 2008 Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease World J Gastroenterol 14 2 176 179 10.3748/wjg.14.176 18186551
26. T Kuhne V Blanchette GR Buchanan U Ramenghi H Donato RY Tamminga, et al. 2007 Splenectomy in children with idiopathic thrombocytopenic purpura: a prospective study of 134 children from the Intercontinental Childhood ITP Study Group Pediatr Blood Cancer 49 6 829 834 10.1002/pbc.21108 17171689
27. AT Nurden JF Viallard P Nurden 2009 New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura Lancet 373 9674 1562 1569 10.1016/S0140-6736(09)60255-5 1:CAS:528:DC%2BD1MXltlaqurY%3D 19324405
28. Z Zhou L Yang Z Chen X Chen Y Guo X Wang, et al. 2007 Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China Eur J Haematol 78 6 518 523 10.1111/j.1600-0609.2007.00844.x 17419740
29. R McMillan JB Bussel JN George D Lalla JL Nichol 2008 Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura Am J Hematol 83 2 150 154 10.1002/ajh.20992 17722072
30. RJ Klaassen VS Blanchette D Barnard CD Wakefield C Curtis CS Bradley, et al. 2007 Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools J Pediatr 150 5 510 515 10.1016/j.jpeds.2007.01.037 17452226 5 e1
31. CE Neunert GR Buchanan V Blanchette D Barnard NL Young C Curtis, et al. 2009 Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura Pediatr Blood Cancer 53 4 652 654 10.1002/pbc.21978 19492316